Clinical Trial Update: A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update of aripiprazole in pediatric patients with autism; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Autistic Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-04-11